Close Menu

NEW YORK (360Dx) – During February the US Food and Drug Administration cleared in vitro diagnostic tests from Roche Diagnostics, Beckman Coulter, Thermo Fisher Scientific, BioMérieux, and others, according to the agency's website.

Roche Diagnostics received clearance for its Ammonia II assay, an enzymatic test for the measurement of ammonia in human plasma, running on Roche's Cobas c systems. The ammonia measurements are used in the diagnosis and treatment of severe liver disorders, such as cirrhosis, hepatitis, and Reye's syndrome.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.